Endometrial patterns during therapy with danazol or Gestrinone (cas 16320-04-0) for endometriosis: Structural and ultrastructural study

Add time:08/09/2019    Source:sciencedirect.com

We treated 36 women with laparoscopically proven endometriosis with danazol 600 mg/d (n = 17) or Gestrinone (cas 16320-04-0) 5.0 mg/wk (n = 19) for 6 months. Endometrial samples were obtained before and at 3 and 6 months of treatment and were studied by light, scanning, and transmission electron microscopy. At 3 months of treatment, the endometria of the danazol-treated patients were more atrophic than those of the women who received gestrinone. Some cell organelle involution was evident in patients of both treatment groups. After 6 months of treatment, marked endometrial atrophy was observed in all the patients, including those in whom spotting had occurred. The ultrastructural investigation demonstrated complete involution of the cytoplasmic organelles with cytoplasmic collapse in glandular cells of patients treated with danazol, whereas in the gestrinone group degeneration phenomena were observed in both nucleus and cytoplasm. Irregular secretory transformation was seen in the endometria of patients in both groups. Long-term treatment with danazol caused endometrial atrophy similar to that induced by gestrinone, but it appeared earlier; thus, the former drug seems preferable in short-term treatment.

We also recommend Trading Suppliers and Manufacturers of Gestrinone (cas 16320-04-0). Pls Click Website Link as below: cas 16320-04-0 suppliers

Prev:Individual and combined effects of triptoreline and Gestrinone (cas 16320-04-0) on experimental endometriosis in rats
Next:Synthesis and properties of blue-light-emitting Oligo(fluorene-co-dibenzothiophene-S,S-dioxide)s)